Overview

Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
In this study, our aim is to investigate the role tranexamic acid in modulating inflammation in patients with sepsis.
Phase:
Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Tranexamic Acid